Prostate Specific Antigen Levels during Testosterone Treatment of Hypogonadal Older Men: Data from a Controlled Trial

Prostate-specific antigen (PSA) changes during testosterone treatment of older hypogonadal men have not been rigorously evaluated. Double-blinded, placebo-controlled trial. Twelve US academic medical centers. Seven hundred ninety hypogonadal men ≥65 years of age with average testosterone levels ≤275...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The journal of clinical endocrinology and metabolism 2019-12, Vol.104 (12), p.6238-6246
Hauptverfasser:	Cunningham, Glenn R, Ellenberg, Susan S, Bhasin, Shalender, Matsumoto, Alvin M, Parsons, J Kellogg, Preston, Peter, Cauley, Jane A, Gill, Thomas M, Swerdloff, Ronald S, Wang, Christina, Ensrud, Kristine E, Lewis, Cora E, Pahor, Marco, Crandall, Jill P, Molitch, Mark E, Cifelli, Denise, Basaria, Shehzad, Diem, Susan J, Stephens-Shields, Alisa J, Hou, Xiaoling, Snyder, Peter J
Format:	Artikel
Sprache:	eng
Schlagworte:	Antigens Care and treatment Clinical s Clinical trials Health aspects Hormone replacement therapy Pharmaceutical industry Prostate cancer Prostate-specific antigen Testosterone
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!